Reid; Julia
Patent Applications and Registrations
Patent applications and USPTO patent grants for Reid; Julia.The latest application filed is for "gene signatures for cancer prognosis".
- Reid; Julia - Salt Lake City UT
| Patent | Date |
|---|---|
| Gene Signatures For Cancer Prognosis App 20220112565 - Stone; Steven ; et al. | 2022-04-14 |
| Gene signatures for cancer prognosis Grant 11,174,517 - Stone , et al. November 16, 2 | 2021-11-16 |
| Gene Signatures For Cancer Prognosis App 20210071269 - Stone; Steven ; et al. | 2021-03-11 |
| Gene signatures for cancer prognosis Grant 10,876,164 - Stone , et al. December 29, 2 | 2020-12-29 |
| Method Of Using Biomarkers And Clinical Variables For Predicting Chemotherapy Benefit App 20200283855 - GUTIN; Alexander ; et al. | 2020-09-10 |
| Cancer Biomarkers App 20200056246 - STONE; Steven ; et al. | 2020-02-20 |
| Cancer Biomarkers Grant 10,519,513 - Stone , et al. Dec | 2019-12-31 |
| Cancer biomarkers Grant 10,501,807 - Stone , et al. Dec | 2019-12-10 |
| Methods and materials for assessing homologous recombination deficiency Grant 10,400,287 - Abkevich , et al. Sep | 2019-09-03 |
| Methods And Materials For Assessing Homologous Recombination Deficiency App 20190185939 - Abkevich; Victor ; et al. | 2019-06-20 |
| Cancer Biomarkers App 20190153542 - Stone; Steven ; et al. | 2019-05-23 |
| Cancer Biomarkers App 20180265930 - Stone; Steven ; et al. | 2018-09-20 |
| Cancer biomarkers Grant 9,976,188 - Stone , et al. May 22, 2 | 2018-05-22 |
| Methods And Materials For Assessing Homologous Recombination Deficiency App 20170283879 - Abkevich; Victor ; et al. | 2017-10-05 |
| Cancer Biomarkers App 20170247768 - Stone; Steven ; et al. | 2017-08-31 |
| Gene Signatures For Cancer Prognosis App 20170152571 - Stone; Steven ; et al. | 2017-06-01 |
| Gene Signatures For Cancer Diagnosis And Prognosis App 20170096712 - Stone; Steven ; et al. | 2017-04-06 |
| Gene signatures for cancer diagnosis and prognosis Grant 9,605,319 - Stone , et al. March 28, 2 | 2017-03-28 |
| Gene Signatures For Renal Cancer Prognosis App 20160281177 - Stone; Steven ; et al. | 2016-09-29 |
| Gene Signatures For Cancer Prognosis App 20150247208 - Stone; Steven ; et al. | 2015-09-03 |
| Cancer Biomarkers App 20150232947 - Stone; Steven ; et al. | 2015-08-20 |
| Gene Signatures For Lung Cancer Prognosis And Therapy Selection App 20140315935 - Wagner; Susanne ; et al. | 2014-10-23 |
| Hypoxia-related Gene Signatures For Cancer Classification App 20140212415 - Gutin; Alexander ; et al. | 2014-07-31 |
| Gene Signatures For Lung Cancer Prognosis And Therapy Selection App 20140170242 - Wagner; Susanne ; et al. | 2014-06-19 |
| Gene Signatures For Cancer Diagnosis And Prognosis App 20130302242 - Stone; Steven ; et al. | 2013-11-14 |
| Gene Signatures For Cancer Prognosis App 20120053253 - Stone; Steven ; et al. | 2012-03-01 |
| Cancer Biomarkers App 20120041274 - Stone; Steven ; et al. | 2012-02-16 |
| Gene variants and use thereof App 20070082347 - Lanchbury; Jerry ; et al. | 2007-04-12 |
| Drug response marker in beta-1 adrenergic receptor gene Grant 7,195,873 - Filigheddu , et al. March 27, 2 | 2007-03-27 |
| Drug response marker in beta-1 adrenergic receptor gene App 20030143608 - Filigheddu, Fabiana ; et al. | 2003-07-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 